Cartesian Therapeutics, Inc. Shares Outstanding (Cover Page)
Cartesian Therapeutics, Inc. (RNAC) had Shares Outstanding (Cover Page) of 30.26 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 30.26M shares.
- 2026-04-23: Entity Common Stock, Shares Outstanding 29.38M shares.
- 2026-02-28: Entity Common Stock, Shares Outstanding 26.51M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 26.00M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 30.26M shares 10-Q · filed 2026-08-06 |
| 2026-04-23 | 29.38M shares 10-Q · filed 2026-04-30 |
| 2026-02-28 | 26.51M shares 10-K · filed 2026-03-09 |
| 2025-10-31 | 26.00M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 26.00M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 25.95M shares 10-Q · filed 2025-05-08 |
| 2025-02-28 | 25.91M shares 10-K · filed 2025-03-13 |
| 2024-11-01 | 25.41M shares 10-Q · filed 2024-11-07 |
| 2024-08-07 | 21.38M shares 10-Q · filed 2024-08-08 |
| 2024-05-03 | 17.80M shares 10-Q · filed 2024-05-08 |
| 2024-03-01 | 161.95M shares 10-K · filed 2024-03-07 |
| 2023-11-10 | 155.20M shares 10-Q · filed 2023-11-13 |
| 2023-08-04 | 153.43M shares 10-Q · filed 2023-08-17 |
| 2023-04-28 | 153.43M shares 10-Q · filed 2023-05-04 |
| 2023-02-24 | 153.32M shares 10-K · filed 2023-03-02 |
| 2022-10-28 | 153.03M shares 10-Q · filed 2022-11-03 |
| 2022-08-02 | 152.71M shares 10-Q · filed 2022-08-08 |
| 2022-04-29 | 151.81M shares 10-Q · filed 2022-05-05 |
| 2022-04-22 | 151.81M shares 10-K/A · filed 2022-04-28 |
| 2022-03-04 | 124.29M shares 10-K · filed 2022-03-10 |
| 2021-11-05 | 116.65M shares 10-Q · filed 2021-11-09 |
| 2021-08-06 | 115.08M shares 10-Q · filed 2021-08-12 |
| 2021-05-07 | 113.19M shares 10-Q · filed 2021-05-13 |
| 2021-03-05 | 112.37M shares 10-K · filed 2021-03-12 |
| 2020-10-30 | 108.03M shares 10-Q · filed 2020-11-05 |
| 2020-07-31 | 107.14M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 87.49M shares 10-Q · filed 2020-05-07 |
| 2020-03-06 | 86.42M shares 10-K · filed 2020-03-12 |
| 2019-11-04 | 48.20M shares 10-Q · filed 2019-11-08 |
| 2019-08-02 | 44.96M shares 10-Q · filed 2019-08-08 |
| 2019-05-03 | 44.79M shares 10-Q · filed 2019-05-09 |
| 2019-03-08 | 44.73M shares 10-K · filed 2019-03-15 |
| 2018-11-02 | 22.43M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 22.40M shares 10-Q · filed 2018-08-08 |
| 2018-05-04 | 22.35M shares 10-Q · filed 2018-05-09 |
| 2018-03-09 | 22.35M shares 10-K · filed 2018-03-15 |
| 2017-11-03 | 22.34M shares 10-Q · filed 2017-11-07 |
| 2017-08-04 | 22.07M shares 10-Q · filed 2017-08-11 |
| 2017-05-05 | 18.58M shares 10-Q · filed 2017-05-11 |
| 2017-03-17 | 18.48M shares 10-K · filed 2017-03-28 |
| 2016-11-10 | 18.19M shares 10-Q · filed 2016-11-10 |
| 2016-08-08 | 18.19M shares 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |